The ravages of corona virus have triggered an urgent need for a vaccine. Vaccine development has been shortened from the conventional 8-10 years to 1-2 years, placing new technical requirements on accelerating the entire vaccine development and process. As a magic tool for vaccine development, BLI technology has made its presence felt in corona virus vaccine development. The BLI technology used is also a standard method in the US Pharmacopeia for binding activity and quantitative assays, which can accelerate vaccine development in the following ways.
CD BioSciences provides you with a variety of BLI technology for vaccine R&D service to meet your scientific research needs.
1. Rapid determination of vaccine concentration
The receptor or antibody against the vaccine is cured on the sensor and then the vaccine potency (concentration) is quickly measured. The whole experiment can be done in less than 10 minutes and the concentration range is 0.1-1000 ug/mL, covering the concentration range during vaccine production, and the sample often does not need to be diluted.
2. Vaccine binding activity studies
Vaccines based on recombinant proteins or mRNA are generally spike protein structural domains whose binding activity to the receptor ACE2 reflects their conformational correctness and is a prerequisite for neutralizing antibody production. We have additional advantages in measuring binding activity.
3. Vaccine evaluation - determination of antibody potency in serum
Potency testing of immune sera against vaccines is also an important indicator of the immunogenicity of vaccines. Vaccines are generally cured on the sensor and immunized animal/human sera at different dilutions are tested directly to quickly detect the potency of antibodies in the serum, and the binding capacity of antibodies can be known by calculating the dissociation constant or binding signal.
4. Vaccine evaluation - protective antigen epitope detection
The affinity of a vaccine to a series of known epitopes of neutralizing antibodies is measured to determine whether the vaccine maintains the correct conformation and to determine the ability to induce neutralizing antibody epitopes. It is mainly used for subunit vaccines and VLP vaccines.
Please inform us of your specific BLI technology for vaccine R&D service details, and we can provide customized solutions for different projects.
CD BioSciences is a specialized biofilm technology company with the ability to specialize in services such as biofilm analysis in an efficient and precise manner. With outstanding staff, state-of-the-art technology and facilities, CD BioSciences can provide you with a comprehensive range of biofilm BIL technologies. Please feel free to contact us for more detailed information, our scientists will tailor the most reasonable plan for your project.
CD BioSciences is a specialized company providing biofilm services with expertise in the intersection of chemistry and biophysics. Our platform offers advanced technologies to meet all your biofilm needs.
Copyright © CD BioSciences. All Rights Reserved.